ZA876731B - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number: ZA876731B
Authority: ZA; South Africa
Prior art keywords: aluminium hydroxide; ibuprofen; therapeutic agents; aluminium; salt
Prior art date: 1986-10-01

Application number

ZA876731A

Other languages

English (en)

Inventor

Govind Pankhania Mahendra

John Lewis Colin

Original Assignee

The Boots Company Plc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-10-01

Filing date

1987-09-09

Publication date

1988-03-14

1987-09-09 Application filed by The Boots Company Plc. filed Critical The Boots Company Plc.

1988-03-14 Publication of ZA876731B publication Critical patent/ZA876731B/xx

Links

239000003814 drug Substances 0.000 title 1
229940124597 therapeutic agent Drugs 0.000 title 1
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 abstract 4
229910021502 aluminium hydroxide Inorganic materials 0.000 abstract 4
PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 abstract 3
HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 abstract 3
229960001680 ibuprofen Drugs 0.000 abstract 3
150000003839 salts Chemical class 0.000 abstract 2
235000019658 bitter taste Nutrition 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

ZA876731A 1986-10-01 1987-09-09 Therapeutic agents ZA876731B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB868623557A GB8623557D0 (en)	1986-10-01	1986-10-01	Therapeutic agents

Publications (1)

Publication Number	Publication Date
ZA876731B true ZA876731B (en)	1988-03-14

Family

ID=10605072

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA876731A ZA876731B (en)	1986-10-01	1987-09-09	Therapeutic agents

Country Status (16)

Country	Link
US (1)	US4831058A (da)
EP (1)	EP0264187B1 (da)
JP (1)	JPS63101321A (da)
KR (1)	KR950009090B1 (da)
AT (1)	ATE58471T1 (da)
AU (1)	AU594607B2 (da)
CA (1)	CA1306686C (da)
DE (1)	DE3766343D1 (da)
DK (1)	DK503687A (da)
ES (1)	ES2031904T3 (da)
GB (1)	GB8623557D0 (da)
GR (1)	GR3001284T3 (da)
IE (1)	IE61062B1 (da)
NZ (1)	NZ221962A (da)
PT (1)	PT85829B (da)
ZA (1)	ZA876731B (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3639038C2 (de) *	1986-11-14	1997-02-06	Helmut Dr Lukas	Verwendung von S-(+)-Ibuprofen zur schnellen Behandlung humaner Schmerzen
IT1226549B (it) *	1988-07-12	1991-01-24	Resa Farma	Composizioni farmaceutiche ad attivita' analgesica ed antiinfiammatoria per uso orale, dotate di ottima palatabilita' ed esenti da effetti irritanti sulle mucose.
US4916161A (en) *	1988-10-25	1990-04-10	Bristol-Myers Squibb	Taste-masking pharmaceutical agents
DE3938227C1 (en) *	1989-11-17	1991-05-02	Dolorgiet Gmbh & Co Kg, 5205 St Augustin, De	Oral antiinflammatory and analgetic pharmaceutical compsn. - comprises magnesium ibuprofen dissolved in mixt. of water, propane-1,2-diol and glycerol
US5380535A (en) *	1991-05-28	1995-01-10	Geyer; Robert P.	Chewable drug-delivery compositions and methods for preparing the same
ES2202302T3 (es) *	1991-05-28	2004-04-01	Mcneil-Ppc, Inc.	Composicion masticable que libera un farmaco.
US5605930A (en) *	1991-10-21	1997-02-25	The United States Of America As Represented By The Department Of Health And Human Services	Compositions and methods for treating and preventing pathologies including cancer
US5409709A (en) *	1991-11-29	1995-04-25	Lion Corporation	Antipyretic analgesic preparation containing ibuprofen
US5288507A (en) *	1992-07-29	1994-02-22	Merck & Co., Inc.	Ibuprofen antacid combinations
AU699192B2 (en) *	1993-08-13	1998-11-26	Bayer Corporation	Hydrolyzed gelatin as a flavor enhancer in a chewable tablet
US5686109A (en) *	1993-12-10	1997-11-11	Fujisawa Pharmaceutical Co., Ltd.	Antipyretic analgesic composition
IT1270239B (it) *	1994-06-17	1997-04-29	Zambon Spa	Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
US5639475A (en) *	1995-02-03	1997-06-17	Eurand America, Incorporated	Effervescent microcapsules
DE19529862A1 (de) *	1995-08-14	1997-02-20	Rhone Poulenc Rorer Gmbh	Pharmazeutische, oral anwendbare Zubereitung
GB9625589D0 (en)	1996-12-10	1997-01-29	Boots Co Plc	Therapeutic agents
US6376481B2 (en) *	1998-09-02	2002-04-23	Mcneil-Ppc, Inc.	Sterol esters in tableted solid dosage forms
AU753476B2 (en) *	1998-11-25	2002-10-17	Cima Labs, Inc.	Taste masking rapid release coating system
US6740341B1 (en)	1998-11-25	2004-05-25	Cima Labs Inc.	Taste masking rapid release coating system
IE990159A1 (en) *	1999-02-26	2000-09-20	Fuisz Internat Ltd	Storage Stable Amoxycillin and Clavulanate Suspension Composition.
JP5519890B2 (ja) *	2001-02-28	2014-06-11	エスエス製薬株式会社	経口用イブプロフェン製剤
AU2002327418A1 (en) *	2001-08-01	2003-02-17	Bristol-Myers Squibb Company	Taste masking composition
MXPA04008720A (es) *	2002-03-12	2004-12-06	Squibb Bristol Myers Co	Suspension oral de sabor agradable y metodo.
FR2850275B1 (fr)	2003-01-24	2005-04-08	Scherer Technologies Inc R P	Capsules molles a macher contenant une substance active a gout masque
EP1942877A4 (en) *	2005-11-02	2011-09-14	Teikoku Pharma Usa Inc	ORGANOLEPTICALLY ACCEPTABLE ORAL DOSAGE FORMS OF IBUPROFEN, MANUFACTURING METHOD AND APPLICATION
EP2158913A1 (en) *	2008-08-25	2010-03-03	Ratiopharm GmbH	Pharmaceutical composition comprising N-[3-chhloro-4-[(3-fluorophenyl)methoxy]phenyl]6-(5[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furyl]-4-quinazolinamine
JP5740896B2 (ja) *	2009-10-27	2015-07-01	ライオン株式会社	解熱鎮痛組成物
JP6140570B2 (ja) *	2013-08-13	2017-05-31	ライオン株式会社	イブプロフェン含有錠剤及びその製造方法
US9498433B1 (en) *	2013-09-30	2016-11-22	Make Ideas, LLC	Edible animal medicine container
US10821073B1 (en)	2013-09-30	2020-11-03	Make Ideas, LLC	Edible animal medicine container
JP6877923B2 (ja) *	2016-09-06	2021-05-26	ライオン株式会社	内服用半固形製剤及びその製造方法
US11503806B1 (en)	2018-06-12	2022-11-22	Make Ideas Llc	Dog dental device with brushes extending through compressible outer shell
BR112021009468A2 (pt) *	2018-11-16	2021-08-10	Ssp Co., Ltd.	formulação farmacêutica oral contendo ibuprofeno

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3636200A (en) *	1969-06-09	1972-01-18	Hoffmann La Roche	Pharmaceutical suspension
DE2213704C3 (de) *	1971-03-22	1975-06-12	Teikoku Hormone Manufacturing Co. Ltd., Tokio	07.03.72 Japan 22767-72 Verfahren zur Herstellung von Aluminiumsalzen von Carboxylgruppen enthaltenden, pharmazeutisch wirksamen Verbindungen
GB1435892A (en) *	1972-07-04	1976-05-19	Beecham Group Ltd	Aluminium complexes of guaiphenesin
GB1451541A (en) *	1974-02-16	1976-10-06	Lilly Co Eli	Aluminum salts of substituted phenyl-alkanoic acids and pharma ceutical suspensions prepared therefrom core-sampling device for obtaining a core sample from a loose
CA1062721A (en) *	1975-12-15	1979-09-18	Anthony A. Sinkula	Propionic acid derivatives
US4145440A (en) *	1977-08-18	1979-03-20	The Upjohn Company	Liquid suspension of an aluminum salt of ibuprofen
US4361580A (en) *	1980-06-20	1982-11-30	The Upjohn Manufacturing Company	Aluminum ibuprofen pharmaceutical suspensions
SE8103843L (sv) *	1981-06-18	1982-12-19	Astra Laekemedel Ab	Farmaceutisk mixtur
EP0094116A3 (en) *	1982-05-06	1984-08-01	The Procter & Gamble Company	Therapeutic granules
IT1175941B (it) *	1984-02-16	1987-08-12	Stabil Bioterapico Farmachim	Sali d'alluminio mono, bi e trisostituiti degli acidi aril-alcanoici e composizioni farmaceutiche che li contengono
US4753800A (en) *	1985-10-04	1988-06-28	Warner-Lambert Company	Medicament adsorbates and their preparation
AT385894B (de) *	1985-10-04	1988-05-25	Basem Dr Nashef	Schlauchfoermige sonde
US4716033A (en) *	1986-03-27	1987-12-29	Warner-Lambert Company	Medicament adsorbates with surfactant and their preparation

1986
- 1986-10-01 GB GB868623557A patent/GB8623557D0/en active Pending
1987
- 1987-09-08 IE IE240087A patent/IE61062B1/en not_active IP Right Cessation
- 1987-09-09 ES ES198787307943T patent/ES2031904T3/es not_active Expired - Lifetime
- 1987-09-09 DE DE8787307943T patent/DE3766343D1/de not_active Expired - Lifetime
- 1987-09-09 ZA ZA876731A patent/ZA876731B/xx unknown
- 1987-09-09 AT AT87307943T patent/ATE58471T1/de not_active IP Right Cessation
- 1987-09-09 EP EP87307943A patent/EP0264187B1/en not_active Expired - Lifetime
- 1987-09-25 DK DK503687A patent/DK503687A/da not_active Application Discontinuation
- 1987-09-28 NZ NZ221962A patent/NZ221962A/xx unknown
- 1987-09-29 PT PT85829A patent/PT85829B/pt not_active IP Right Cessation
- 1987-09-29 CA CA000548177A patent/CA1306686C/en not_active Expired - Lifetime
- 1987-09-30 AU AU79218/87A patent/AU594607B2/en not_active Ceased
- 1987-09-30 KR KR1019870010896A patent/KR950009090B1/ko not_active Expired - Fee Related
- 1987-09-30 JP JP62247766A patent/JPS63101321A/ja active Pending
- 1987-09-30 US US07/102,863 patent/US4831058A/en not_active Expired - Lifetime
1991
- 1991-01-03 GR GR91400006T patent/GR3001284T3/el unknown

Also Published As

Publication number	Publication date
ATE58471T1 (de)	1990-12-15
KR950009090B1 (ko)	1995-08-14
CA1306686C (en)	1992-08-25
NZ221962A (en)	1990-03-27
JPS63101321A (ja)	1988-05-06
ES2031904T3 (es)	1993-01-01
DK503687D0 (da)	1987-09-25
PT85829B (pt)	1990-07-31
EP0264187B1 (en)	1990-11-22
AU594607B2 (en)	1990-03-08
GR3001284T3 (en)	1992-08-26
PT85829A (en)	1987-10-01
EP0264187A1 (en)	1988-04-20
IE872400L (en)	1989-03-08
DE3766343D1 (de)	1991-01-03
IE61062B1 (en)	1994-09-21
DK503687A (da)	1988-04-02
AU7921887A (en)	1988-04-14
US4831058A (en)	1989-05-16
KR880004807A (ko)	1988-06-27
GB8623557D0 (en)	1986-11-05

Publication	Publication Date	Title
GB8623557D0 (en)	1986-11-05	Therapeutic agents
AU645555B2 (en)	1994-01-20	Improvements in or relating to the treatment of gastrointestinal disorders
CH680983C1 (da)	2008-06-25
PL318649A1 (en)	1997-07-07	Preparation to be administered by inhalation
CA2093806A1 (en)	1992-04-11	Method of treating or preventing type 1 diabetes by oral administration of insulin
AU644094B2 (en)	1993-12-02	Medicaments
AU6060896A (en)	1996-10-03	Oral 1alpha-hydroxyprevitamin D
IL80149A (en)	1990-11-29	Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
DE59410151D1 (de)	2002-08-14	Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
CA2066403A1 (en)	1991-03-06	Transmucosal dosage form
IL102814A0 (en)	1993-01-31	Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
CA2202397A1 (en)	1996-04-25	Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and methods for treatment of metabolic and cardiovascular disorders
HK80492A (en)	1992-10-30	Pharmaceutical compositions with analgesic properties and the preparation and use thereof
NZ225950A (en)	1991-10-25	Calcium citrate malate in the molar ratio of 6:2:3; pharmaceutical compositions
AU3318389A (en)	1989-10-26	Azelastine-containing medicaments with controlled release of the active substance
GR890100833A (en)	1991-03-15	Process for the preparation of a compound with gastric inhibitopy effect
GB1487334A (en)	1977-09-28	Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof
CA2078869A1 (en)	1991-09-24	Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
DE3380294D1 (en)	1989-09-07	Pharmaceutical compositions in oral dosage form
GR3031360T3 (en)	2000-01-31	Composition based on ibuprofen, for oral usage
MY111155A (en)	1999-09-30	Medicaments